Channels - Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment‐Resistant Depression: A Qualitative Study

Similar Items: Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment‐Resistant Depression: A Qualitative Study

Quick Look
Computational spirits: a neuroscientific account of psychedelic entity encounters
Quick Look
Clinical Efficacy of Integrated Acupuncture and Moxibustion Therapy Combined with Drugs in the Treatment of Acute Depressive Disorder: Protocol for a Pragmatic Randomized Controlled Trial
Quick Look
Prevalence and predictors of sexual and physical violence during psychedelic use in a US population‐based study
Quick Look
Restoring oscillatory dynamics in Alzheimer’s disease: A laminar whole-brain model of serotonergic psychedelic effects
Quick Look
Flashbacks Through Time: Historical Development and Current Use of the Term “Flashback” in Psychedelic and Post‐Traumatic Stress Disorder Research
Quick Look
A Missing Voice? Peer Support Workers’ Perceptions of Psychedelic‐Assisted Therapy in Australia: A Cross‐Sectional Survey
Quick Look
Clinical Characteristics, Treatment Patterns, and Drug-Resistant Epilepsy Among Emirati Adults with Epilepsy
Quick Look
Occurrence and clinical correlates of depressive symptoms in adults with epilepsy: A study in Georgia
Quick Look
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial
Quick Look
Clinical Characteristics Associated With Response and Remission From Depression Using Measurement‐Based Care
Quick Look
Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report
Quick Look
A first in disease trial of the safety, tolerability, and anti‐seizure effects of ES‐481 in drug‐resistant epilepsy
Quick Look
Evaluating the Clinical Utility of the Interpersonal Hopelessness Scale Among Adults With Past‐Year Suicide Ideation
Quick Look
Prevalence and Association of Somatic Symptoms with Depression Severity in Major Depressive Disorder Patients at Suanprung Psychiatric Hospital
Quick Look
A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing–Remitting Multiple Sclerosis
Quick Look
Follow-up of the first depressive episode: prevalence and factors associated with the development of recurrent depressive disorder and bipolar affective disorder
Quick Look
Insulin Resistance Across Cerebrovascular and Related Disorders: Mechanisms, Measurement, Genetics, and Clinical Implications
Quick Look
Depression in adolescents exposed to war trauma Risk factors for development of depression in adolescents exposed to war trauma: does PTSD matter?
Quick Look
Development of an Empowerment Program for Patients with Depression and Suicidal Ideation
Quick Look
Secondhand Smoke Exposure and Depressive Symptoms Among Nonsmokers in China
Quick Look
Identification of Shared Genetic Variants and Haplotypes Associated With Schizophrenia and Depression
Quick Look
Clozapine as an Off-Label Treatment for Severe and Treatment-Resistant (Auto-)Aggressive Behavior in a 40-Year-Old Patient With Mild Intellecutal Disability and Borderline Personality Disorder
Quick Look
“Dream Insertion”: A Case Report of a Novel Psychotic Symptom in a Male Inpatient With Treatment Resistant Schizophrenia
Quick Look
The use of botulinum toxin type A in the treatment of chronic drug-resistant pain in a patient with type 1 neurofibromatosis